These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 17564176)
1. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. Smith JS; Lal A; Harmon-Smith M; Bollen AW; McDermott MW J Neurosurg; 2007 Jun; 106(6):1034-40. PubMed ID: 17564176 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas. Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of EGFR expression in de novo and progressed atypical and anaplastic meningiomas: an immunohistochemical and fluorescence in situ hybridization pilot study. Caltabiano R; Barbagallo GM; Castaing M; Cassenti A; Senetta R; Cassoni P; Albanese V; Lanzafame S J Neurosurg Sci; 2013 Jun; 57(2):139-51. PubMed ID: 23486338 [TBL] [Abstract][Full Text] [Related]
5. Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy. Hatiboglu MA; Cosar M; Iplikcioglu AC; Ozcan D Surg Neurol; 2008 Apr; 69(4):356-62; discussion 362-3. PubMed ID: 17707480 [TBL] [Abstract][Full Text] [Related]
6. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas. Lee SH; Lee YS; Hong YG; Kang CS APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227 [TBL] [Abstract][Full Text] [Related]
8. [Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study]. Wang CL; Mei JH; Wang SS; Xu S; Xu LL; Xiong YF Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):156-60. PubMed ID: 20450760 [TBL] [Abstract][Full Text] [Related]
9. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [TBL] [Abstract][Full Text] [Related]
10. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas. Yang SY; Xu GM J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Karamitopoulou E; Perentes E; Tolnay M; Probst A Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273 [TBL] [Abstract][Full Text] [Related]
12. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression. Nagashima G; Asai J; Suzuki R; Fujimoto T Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968 [TBL] [Abstract][Full Text] [Related]
13. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. Ozen O; Demirhan B; Altinörs N Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545 [TBL] [Abstract][Full Text] [Related]
14. CD90 expression in atypical meningiomas and meningioma metastasis. Scognamiglio G; D'Antonio A; Rossi G; Cavazza A; Camerlingo R; Pirozzi G; La Mantia E; Anniciello AM; Morabito A; Cantile M; Boscaino A; Sparano L; Botti G; Rocco G; Franco R Am J Clin Pathol; 2014 Jun; 141(6):841-9. PubMed ID: 24838329 [TBL] [Abstract][Full Text] [Related]
15. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Abramovich CM; Prayson RA Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827 [TBL] [Abstract][Full Text] [Related]
16. Sex steroid and growth factor profile of a meningioma associated with pregnancy. Smith JS; Quiñones-Hinojosa A; Harmon-Smith M; Bollen AW; McDermott MW Can J Neurol Sci; 2005 Feb; 32(1):122-7. PubMed ID: 15825560 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837 [TBL] [Abstract][Full Text] [Related]
18. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. Palma L; Celli P; Franco C; Cervoni L; Cantore G J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894 [TBL] [Abstract][Full Text] [Related]
19. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937 [TBL] [Abstract][Full Text] [Related]
20. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Ho DM; Hsu CY; Ting LT; Chiang H Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]